CiCHD researchers develop groundbreaking human-based model for Fontan-associated liver disease
Researchers at the Center for Innovation in Congenital Heart Disease (CiCHD) at UTHealth Houston have developed a first-of-its-kind, human-based model designed to advance understanding and treatment of Fontan-associated liver disease (FALD), a serious and increasingly recognized complication affecting survivors of…
CiCHD researchers publish groundbreaking 3D bioprinted model of early human heart development in Nature Communications
Researchers affiliated with the Center for Innovation in Congenital Heart Disease (CiCHD) have published a landmark study in Nature Communications introducing what is believed to be the first fully human-based, 3D bioprinted, and perfused model of the embryonic heart tube—the…
Rapid funding fuels momentum for CiCHD
Since its official launch in March 2026, the Center for Innovation in Congenital Heart Disease (CiCHD) has received more than $1.1 million in grants and support to drive their research. The newly awarded $650,000 Additional Ventures grant will support the…
Pediatric cardiology home to new center driving breakthroughs in congenital heart disease
[Adapted from New center driving breakthroughs in congenital heart disease] A new multidisciplinary center at McGovern Medical School at UTHealth Houston is bringing together experts across medicine, science, and engineering to transform how congenital heart disease is understood and treated…